ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer

Overview of attention for article published in Science Advances, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 3 news outlets

twitter: 13 X users

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 75 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Discovery of a cancer promoter offers pathway to overcome drug resistance. ecancer

ecancer, 12 Sep 2018

Geneticists at St. Jude Children's Research Hospital have discovered a previously unknown cell growth mechanism that makes a…

Discovery of a cancer promoter offers pathway to overcome drug resistance

MedicalXpress, 12 Sep 2018

A chance experiment in the Grosveld laboratory hinted that a third mTOR complex might exist that was assembled by a protein…

Discovery of a cancer promoter offers pathway to overcome drug resistance

EurekAlert!, 12 Sep 2018

Geneticists at St. Jude Children's Research Hospital have discovered a previously unknown cell growth mechanism that makes a…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.